Citi analyst Yigal Nochomovitz raised the firm’s price target on Travere Therapeutics (TVTX) to $48 from $34 and keeps a Buy rating on the shares.
Investor's Business Daily on MSN
UPS Receives Price-Target Hikes Amid Job Cuts But Analyst Makes This Warning
UPS stock soared in Tuesday's stock market after earnings and on Wednesday several analysts raised stock price targets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback